Navigation path

Placing on the market of products subject to conformity assessment B+C2
Good Laboratory Practicies - Product-specific legal acts
FAQ SELECTION OF EU TESTING FACILITIES GRO/IMA/23/2711/13161
EPAA webinar on designathon for human systemic toxicity - questions with answers
Good Laboratory Practicies - Inspected test facilities
FAQ SELECTION OF EU TESTING FACILITIES 325/G/GRO/IMA/22/2711/12562
Call for expression of interest 325/G/GRO/IMA/22/2711/12562 - Documents
Fertilisers - Member states approved laboratories
Keynote I “The Importance of: Innovation, Collaboration and Partnerships” by Patrick Masscheleyn
2020 at a glance: EPAA achievements and new Action Programme by Rob Roggeband
Keynote II “3Rs Milestones and challenges ahead” by Judy MacArthur Clark
Mirror Group perspective by Marina Pereira
2020 EPAA Science Prize: “Human mini-hearts from stem cells to study cardiac disease, cardiotoxicity and to reduce animal experiments” by Dr. Viviana Meraviglia
National 3Rs centers perspective, by Adrian Smith
Global perspective by Anna Lowit
15 years of public-private partnership: EPAA achievements
EPAA Publications 2020
Action Programme 2021-2025 adopted 23 Sept 2020
EPAA annual conference 2020 - preliminary agenda
Current performance of COVID-19 test methods and devices and proposed performance criteria - Working document of Commission services
2019 report on the statistics on the use of animals for scientific purposes in the Member States of the European Union in 2015-2017
REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL on the implementation of Directive 2010/63/EU on the protection of animals used for scientific purposes in the Member States of the European Union
EPAA Annual Conference 2019 Report
Partners Forum 2019 - flash report
EPAA privacy statement on the PROTECTION OF YOUR PERSONAL DATA
Rezultātu skaits lapā: 5 10 15 20 25 | Lappuse 1 no 4

Additional tools

Esiet informēti